RMD Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 22:00):

Stats
Dagens volum	2.13M
Gjennomsnittsvolum	1.06M
Markedsverdi	31.95B
EPS	$0 ( 2024-04-25 )
Last Dividend	$0.480 ( 2023-11-08 )
Next Dividend	$0 ( N/A )
P/E	35.96
ATR14	$0.217 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-04	Rider Michael J	Sell	81	ResMed Common Stock
2024-03-01	Rider Michael J	Sell	200	ResMed Common Stock
2023-05-03	Farrell Peter C	Sell	12 600	ResMed Common Stock
2024-02-22	Farrell Peter C	Sell	10 935	ResMed Common Stock
2024-01-02	Douglas Robert Andrew	Buy	0

INSIDER POWER
13.07
Last 97 transactions
Buy: 212 786 \| Sell: 186 883

Volum Korrelasjon

Lang: 0.67 (moderate)

Kort: 0.80 (strong)

Signal:(73.489) Same movement expected

Resmed Inc Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Resmed Inc Korrelasjon - Valuta/Råvare

-0.13
( neutral )

-0.19
( neutral )

-0.77
( moderate negative )

-0.05
( neutral )

-0.36
( neutral )

-0.12
( neutral )

Resmed Inc Økonomi

Annual	2023
Omsetning:	$4.22B
Bruttogevinst:	$2.36B (55.78 %)
EPS:	$6.12

FY	2023
Omsetning:	$4.22B
Bruttogevinst:	$2.36B (55.78 %)
EPS:	$6.12

FY	2022
Omsetning:	$3.58B
Bruttogevinst:	$2.02B (56.57 %)
EPS:	$5.34

FY	2021
Omsetning:	$3.20B
Bruttogevinst:	$1.84B (57.53 %)
EPS:	$3.27

Financial Reports:

No articles found.

Resmed Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.440 (N/A)	$0.440 (N/A)	$0.440 (N/A)	$0.440 (N/A)	$0.480 (N/A)	$0.480 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Resmed Inc Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.47 - Increase likely (49.48%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.170	2012-09-05
Last Dividend	$0.480	2023-11-08
Next Dividend	$0	N/A
Payout Date	2023-12-14
Next Payout Date	N/A
# dividends	46	--
Total Paid Out	$15.72	--
Avg. Dividend % Per Year	0.54%	--
Score	4.95	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.47
Div. Directional Score	9.24	--

Next Divdend (Est)
(2024-07-01)

$0.490 Estimate 39.56 %

Dividend Stability

0.79 Good

Dividend Score

4.95

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2012	$0.340	1.33%
2013	$0.840	1.98%
2014	$1.060	2.29%
2015	$1.160	2.03%
2016	$1.260	2.41%
2017	$1.360	2.20%
2018	$1.440	1.68%
2019	$1.520	1.36%
2020	$1.560	1.00%
2021	$1.620	0.76%
2022	$1.720	0.66%
2023	$1.840	0.88%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.216	1.500	5.69	8.53	[0 - 0.5]
returnOnAssetsTTM	0.141	1.200	5.31	6.37	[0 - 0.3]
returnOnEquityTTM	0.219	1.500	8.68	10.00	[0.1 - 1]
payoutRatioTTM	0.215	-1.000	7.85	-7.85	[0 - 1]
currentRatioTTM	3.04	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	1.316	0.800	6.97	5.57	[0.8 - 2.5]
cashRatioTTM	0.308	1.500	9.40	10.00	[0.2 - 2]
debtRatioTTM	0.171	-1.500	7.14	-10.00	[0 - 0.6]
interestCoverageTTM	-22.18	1.000	-9.33	-9.33	[3 - 30]
operatingCashFlowPerShareTTM	5.42	2.00	8.19	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.71	2.00	7.65	10.00	[0 - 20]
debtEquityRatioTTM	0.252	-1.500	8.99	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.575	1.000	3.74	3.74	[0.2 - 0.8]
operatingProfitMarginTTM	0.273	1.000	6.54	6.54	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.682	1.000	7.32	7.32	[0.2 - 2]
assetTurnoverTTM	0.652	0.800	8.98	7.19	[0.5 - 2]
Total Score				11.00

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	33.46	1.000	6.72	0	[1 - 100]
returnOnEquityTTM	0.219	2.50	9.15	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.71	2.00	8.43	10.00	[0 - 30]
dividendYielPercentageTTM	0.862	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.42	2.00	8.19	10.00	[0 - 30]
payoutRatioTTM	0.215	1.500	7.85	-7.85	[0 - 1]
pegRatioTTM	11.66	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.179	1.000	8.02	0	[0.1 - 0.5]
Total Score				7.47

Resmed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.